Enhanced nucleotide excision repair capacity in lung cancer cells by preconditioning with DNA-damaging agents

The capacity of tumor cells for nucleotide excision repair (NER) is a major determinant of the efficacy of and resistance to DNA-damaging chemotherapeutics, such as cisplatin. Here, we demonstrate that using lesion-specific monoclonal antibodies, NER capacity is enhanced in human lung cancer cells a...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Ji Ye, Park, Jeong-Min, Yi, Joo Mi, Leem, Sun-Hee, Kang, Tae-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673183/
https://www.ncbi.nlm.nih.gov/pubmed/26317794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673183/
https://www.ncbi.nlm.nih.gov/pubmed/26317794

Ejemplares similares